1. Corrigendum to 'Should treatment of low-level rifampicin mono-resistant tuberculosis be different?' [JCTUBE 23 (2021) 100241]. (August 2021) Authors: Gopie, F.A.; Commiesie, E.; de Lange, W.C.M.; van Soolingen, D.; Vreden, S.G.S.; de Vries, G. Journal: Journal of clinical tuberculosis and other mycobacterial diseases Issue: Volume 24(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Should treatment of low-level mono-resistant tuberculosis be different?. (May 2021) Authors: Gopie, F.A.; Commiesie, E.; de Lange, W.C.M.; van Soolingen, D.; Vreden, S.G.S.; de Vries, G. Journal: Journal of clinical tuberculosis and other mycobacterial diseases Issue: Volume 23(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Should treatment of low-level rifampicin mono-resistant tuberculosis be different?. (May 2021) Authors: Gopie, F.A.; Commiesie, E.; Baldi, S.; Kamst, M.; Kaur, D.; de Lange, W.C.M.; Pinas, P.S.; Stijnberg, D.; Wongsokarijo, M.; Zijlmans, C.W.R.; de Zwaan, R.; van Soolingen, D.; Vreden, S.G.S.; de Vries, G. Journal: Journal of clinical tuberculosis and other mycobacterial diseases Issue: Volume 23(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗